Podcast
MSL Talk: Tom Caravela, Hahn-Ey Lee
IMPOSTER: Why Do I STINK so much
Summary
In this episode, Tom Caravela delves into the pervasive issue of imposter syndrome, sharing personal insights and experiences. He candidly discusses his own encounters with feelings of inadequacy and how he managed to navigate them. Tom offers practical strategies to combat imposter syndrome, emphasizing the importance of self-awareness and positive reinforcement. He encourages listeners to recognize their achievements and maintain a supportive network. The episode wraps up with Tom's final thoughts, urging the audience to engage with the community and take proactive steps towards overcoming self-doubt.
Tom Caravela, Managing Partner at The Carolan Group and Co-Founder of MSL Mastery, discusses the 5 ways to overcome imposter syndrome
Tom shares….
π What is Imposter Syndrome
π How can you overcome imposter syndrome
π What is comparison-itis
π Why should you “touch some grass”
π How to develop a growth mindset
Imposter syndrome, overcoming self-doubt, growth mindset, managing inadequacy, self-awareness strategies
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Hahn-Ey Lee
Podcast
MSL Talk: Tom Caravela, Maria Abunto, Nabhan Islam
Business Acumen: The Other MSL Currency
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary